Provided by Tiger Trade Technology Pte. Ltd.

WisdomTree BioRevolution Fund

23.51
+0.29001.25%
Volume:1K
Turnover:33.94K
Market Cap:3.53M
PE:- -
High:23.51
Open:23.51
Low:23.51
Close:23.22
52wk High:24.20
52wk Low:14.31
Shares:150.00K
Float Shares:150.00K
Volume Ratio:0.52
T/O Rate:0.95%
Dividend:0.77
Dividend Rate:3.28%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

One Great Chart: Moderna Surge Makes S&P History

Dow Jones
·
Aug 20

Moderna price target raised to $89 from $39 at Morgan Stanley

TIPRANKS
·
Aug 20

Moderna Inc. Stock Rallies 177.0%, Outperforms Peers

Dow Jones
·
Aug 20

Moderna's Cancer-Vaccine Breakthrough Drives Broad Biopharma Stock Rally

Dow Jones
·
Aug 20

US Stocks Close: Dow Rises Over 120 Points, SOX Drops 2%; Memory Stocks Lead Losses, SanDisk Falls 3.5%, Moderna Surges 177%

TradingKey
·
Aug 20

US Closing Bell | Unable to generate due to lack of news data

US Closing Bell
·
Aug 20

Moderna Shares More than Double on Success of mRNA Cancer Vaccine

Dow Jones
·
Aug 20

Moderna Raised to Outperform from Market Perform by William Blair

Dow Jones
·
Aug 20

Scorpion Capital Says it is Short Twist Bioscience

Reuters
·
Aug 20

Scorpion Capital: We are Short Twist Biosciences

THOMSON REUTERS
·
Aug 20

Amplitude Therapeutics: Lilly to GET Exclusive, Target-Specific Rights to Develop ,Commercialize Licensed Products Directed to Collaboration Targets

THOMSON REUTERS
·
Aug 20

Amplitude Therapeutics and Lilly Enter Strategic Collaboration to Develop Trans-Amplifying Rna Vaccines for Infectious Diseases

THOMSON REUTERS
·
Aug 20

Amplitude: Initial Programs Target Infectious Diseases with High Unmet Need, with Lilly Retaining Options for up to Two Additional Targets

THOMSON REUTERS
·
Aug 20

World's Largest Companies by Market Cap (July 2026): Nvidia Leads, AI Theme Intact but Chip Stocks Face Valuation Adjustments

TradingKey
·
Aug 20

Piper Sandler Adjusts Price Target on Moderna to $167 From $77, Maintains Overweight Rating

MT Newswires Live
·
Aug 20

BofA Securities Upgrades Moderna to Neutral From Underperform Following Intismeran 'Success', Raises Price Target to $170 From $40

MT Newswires Live
·
Aug 20

Twist Bioscience Shares Rise After Selection by Anthropic to Evaluate Protein Design Project

MT Newswires Live
·
Aug 20

Asia Morning Call-Global Markets

Reuters
·
Aug 20

Top Midday Gainers

MT Newswires Live
·
Aug 20

U.S. Stocks on the MOVE-ServiceNow, Zoom, US Homebuilders

Reuters
·
Aug 20